Navigation Links
Arena and Eisai Announce Results of Re-Adjudication of Rat Mammary Tumors from Lorcaserin Carcinogenicity Study
Date:8/9/2011

SAN DIEGO and WOODCLIFF LAKE, N.J., Aug. 9, 2011 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) and Eisai Inc. announced today results from a Pathology Working Group's (PWG) re-adjudication of female rat mammary tumor diagnoses from a two-year rat carcinogenicity study of lorcaserin. Arena convened the PWG in response to the lorcaserin Complete Response Letter (CRL), which questioned the certainty of the female rat mammary tumor classifications. The PWG reviewed relevant tissues and reported that mammary fibroadenomas (benign tumors) were distinguishable from mammary adenocarcinomas (malignant tumors). The PWG reported shifts in the numbers of both tumor types from the initial report included in the lorcaserin New Drug Application (NDA) and that adenocarcinomas were no longer numerically higher than the control group in the lorcaserin low- and mid-dose groups.

"We believe the PWG's report should further clarify the female rat mammary tumor diagnoses which, in combination with other data, may be helpful in assessing human risk," said William R. Shanahan, M.D., Arena's Senior Vice President and Chief Medical Officer.

The PWG's re-adjudication is one of the activities intended to address the observation of mammary tumors in female rats and is part of the overall plan to submit a response to the lorcaserin CRL. Additional activities intended to address the CRL are ongoing.

Findings from Initial and PWG Reports The PWG consisted of five pathologists contracted by Arena. Arena consulted the US Food and Drug Administration (FDA) in selecting these pathologists. According to the PWG's re-adjudication, the incidence of adenocarcinomas was numerically lower than the control group in both the lorcaserin low (10 mg/kg/day) and mid (30 mg/kg/day) dose groups and was statistically higher than the control group in the lorcaserin high
'/>"/>

SOURCE Arena Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Arena and Eisai Announce Completion of Study Measuring Lorcaserin Concentrations in Human Cerebrospinal Fluid and Related Analyses
2. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, August 9
3. Arena Pharmaceuticals Announces Phase 1 Results for APD811 for Pulmonary Arterial Hypertension
4. Meta-Analyses of Phase 3 Trials Show Obese and Overweight Patients Taking Arena Pharmaceuticals Lorcaserin Achieved Statistically Significant Weight Loss
5. Arena Pharmaceuticals Announces First Quarter 2011 Financial Results and Recent Developments
6. Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference
7. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Tuesday, May 10
8. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
9. Arena Pharmaceuticals Expands GPR119 Patent Portfolio for Type 2 Diabetes
10. Arena Pharmaceuticals to Host Business and Financial Update Conference Call and Webcast on Friday, March 11
11. Arena Pharmaceuticals Announces Upcoming Departure of Chief Financial Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/1/2015)... Pharmacyclics, Inc. (the "Company") (NASDAQ: PCYC ) today ... 2015, as well as general business updates. Due to ... be held. Key Highlights , Total ... to $206 million from $119 million for the quarter ... (ibrutinib) net product revenue of $247 million was ...
(Date:5/1/2015)... 1, 2015  Misonix, Inc. (NASDAQ: MSON ... manufactures and markets innovative therapeutic ultrasonic products for ... surgery, laparoscopic surgery and other surgical applications, announced ... the third quarter fiscal year 2015 on Thursday, ... conference call that same day, Thursday, May 7, ...
(Date:5/1/2015)... -- Shares of Aerie Pharmaceuticals, Inc. (NASDAQ: AERI ) ... results of the Phase 3 Rocket 1 trail of ... to meet its end points, compelling data from the ... studies. An analyst report on AERI that ... analyst summary, valuation, and recommendation can be viewed by ...
Breaking Medicine Technology:Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 2Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 3Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 4Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 5Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 6Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 7Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 8Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 9Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 10Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 11Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 12Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 13Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 14Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 15Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 16Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 17Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 18Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 19Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 20Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 21Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 22Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 23Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 24Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 25Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 26Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 27Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 28Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 29Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 30Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 31Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 32Pharmacyclics Reports First Quarter 2015 Financial Results and Provides Business Updates 33Misonix, Inc. To Report Third Quarter Fiscal Year 2015 Financial Results On Thursday, May 7, 2015 2All is Not Lost for Aerie Pharmaceuticals - VLM Research Issued by BrokerBank Securities, Inc. 2
(Date:5/3/2015)... May 03, 2015 NuevaCare announced today ... two upcoming area seminars. The first event will take ... Regional Stroke Conference to be held at The Magnolia ... Wednesday, May 13 during the Dementia Conference to be ... “These seminars offer an excellent opportunity to learn about ...
(Date:5/2/2015)... As one of only 30 Illinois companies to be ... and Recognition Program (SHARP) certification, Essentra Specialty Tapes ... Department of Labor to host this special event. ... the Occupational Safety and Health Administration’s (“OSHA”) Onsite Consultation ... or exceed all of the necessary regulations and standards, ...
(Date:5/2/2015)... Aliso Viejo, CA (PRWEB) May 02, 2015 ... made exclusively for use in Final Cut Pro X. ... ready for use in Final Cut Pro X . ... a single keyframe with Pixel Film Studios' ProText Kinetic 2. ... drop. Start by staggering two ProText Kinetic presets in ...
(Date:5/2/2015)... On Tuesday April 7th, the patient ... to celebrate improvements in patient care. In 2014 the ... had zero acquired ventilator associated infections, zero central line ... was also recently named a Top Performer by the ... credited the teamwork of staff from all departments involved ...
(Date:5/2/2015)... (PRWEB) May 02, 2015 With the success ... company is proud to welcome Neida Miranda and Alex Shields ... Dental Consulting has over 41 years of combined experience working ... been in the dental field for 8 years. She ... in Waco, Texas. Customer service, positive attitude and showing the ...
Breaking Medicine News(10 mins):Health News:NuevaCare Introduces MnemeTherapy® Approach to Care for Elderly Patients with Alzheimer’s, Stroke and Other Types of Neurodegenerative Conditions 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 2Health News:Essentra Specialty Tapes is Selected to Host Gov. Rauner and the Workers' Memorial Day Celebration 3Health News:Pixel Film Studios Announced the Release of Protext Kinetic 2 for FPCX. 2Health News:East Liverpool City Hospital Celebrates Patient Care Improvements 2Health News:Veatch Dental Consulting Services Welcomes New Team Members 2
... Care Foundation will identify ways to expand access to ... Foundation today announced it has awarded a $200,000 12-month ... Care Foundation (Partners) with the goal of expanding access ... in the Santa Clarita Valley and South Los Angeles. ...
... DIEGO, Jan. 27 Cardium Therapeutics (NYSE Alternext ... today announced the launch of InnerCool,s newly redesigned ... and expanded website highlights InnerCool,s new RapidBlue(TM) high-performance ... and CoolConnect Adapters to allow CoolBlue surface pads ...
... Nova Scotia, Jan. 27 Medusa Medical Technologies ... patient care reporting software, the Siren ePCR Suite(TM) ... Philips HeartStart MRx monitor/defibrillator. This integrated solution ... for patient care and reporting in the pre-hospital ...
... Jan. 27 Midwest Sports Events announced,today that Anthem Blue ... sponsor for three race events in northeastern Wisconsin ... bicycle event in Fond du Lac,and Green Bay Duathlon at ... As the title sponsor, Anthem Blue Cross ...
... tool in the fight against,oral cancer is now being offered ... at http://www.barotzdental.com , determines a,person,s risk for oral cancer ... "About 34,000 Americans are diagnosed with oral cancer each year. ... exceptionally high death rate,because it is routinely discovered late in ...
... Inc. (OTC Bulletin Board: EMED) a leading provider of ... healthcare industry, which recently signed letters of intent to ... a leading provider of HIPAA compliant medical, dental, healthcare ... industry is pleased to announce that it has appointed ...
Cached Medicine News:Health News:The SCAN Foundation Funds New Program for Santa Clarita and South Los Angeles Seniors and Those Who Care for Them 2Health News:The SCAN Foundation Funds New Program for Santa Clarita and South Los Angeles Seniors and Those Who Care for Them 3Health News:Cardium's InnerCool Announces Launch of New Enhanced Website 2Health News:Cardium's InnerCool Announces Launch of New Enhanced Website 3Health News:Cardium's InnerCool Announces Launch of New Enhanced Website 4Health News:Cardium's InnerCool Announces Launch of New Enhanced Website 5Health News:Cardium's InnerCool Announces Launch of New Enhanced Website 6Health News:Cardium's InnerCool Announces Launch of New Enhanced Website 7Health News:Cardium's InnerCool Announces Launch of New Enhanced Website 8Health News:Medusa Medical Technologies Announces Integration of Siren ePCR Suite(TM) with Philips HeartStart MRx Monitor/Defibrillator 2Health News:Medusa Medical Technologies Announces Integration of Siren ePCR Suite(TM) with Philips HeartStart MRx Monitor/Defibrillator 3Health News:Anthem Blue Cross and Blue Shield to Serve as Title Sponsor for Three Race Events in Northeastern Wisconsin 2Health News:Anthem Blue Cross and Blue Shield to Serve as Title Sponsor for Three Race Events in Northeastern Wisconsin 3Health News:Barotz Dental Offers Free Online Oral Cancer Risk Assessment 2Health News:MedCom USA, Inc. Announces Appointment of One New Board Member and Removal of Two Existing Board Members 2Health News:MedCom USA, Inc. Announces Appointment of One New Board Member and Removal of Two Existing Board Members 3
Ideal for use with low volume samples on the Biomek robotic pipetting systems, the ART 20R provides guaranteed protection for your expensive workstation....
... false signals and contamination caused by ... Barrier Tips offer performance and economy ... (PCR(a)), radioactive isotopes, tissue culture fluids, ... , ,Promega Barrier Tips are made ...
... Eppendorf Barrier Tips. Designed to fit Eppendorf Pipettors. ... of DNA and proteins bound to the tip. ... retention, which means the focus is on liquid ... also focuses on low binding which reduces the ...
10 L, Racked, Pre-sterilized, 96 tips/rack Recommended for 2, 5 and 10 L pipettes....
Medicine Products: